Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

U S Global Investors (GROW) Cash & Equivalents (2016 - 2025)

U S Global Investors (GROW) has disclosed Cash & Equivalents for 16 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 96.16% to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2025, down 96.16% year-over-year, with the annual reading at $1.0 million for FY2025, 96.35% down from the prior year.
  • Cash & Equivalents hit $1.0 million in Q4 2025 for U S Global Investors, down from $24.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $27.4 million in Q2 2024 to a low of $1.0 million in Q1 2021.
  • Historically, Cash & Equivalents has averaged $9.7 million across 5 years, with a median of $1.0 million in 2021.
  • Biggest five-year swings in Cash & Equivalents: surged 2633.6% in 2024 and later plummeted 96.35% in 2025.
  • Year by year, Cash & Equivalents stood at $23.2 million in 2021, then crashed by 95.69% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then skyrocketed by 2504.0% to $26.0 million in 2024, then tumbled by 96.16% to $1.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for GROW at $1.0 million in Q4 2025, $24.6 million in Q3 2025, and $1.0 million in Q2 2025.